Bamipine lactate
- Level
- Commodity
- Parent
- 51313200
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313213This classification denotes a histamine-1 receptor antagonist C19H24N2.C3H6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6K8KNJ07D8, chemically known as propanoic acid, 2-hydroxy-, compd. with 1-methyl-n-phenyl-n-(phenylmethyl)-4-piperidinamine (1:1), but more generally known as bamipine lactate, which bears US NIH Compound Identifier 11462853. European Medicines Agency schedules Bamipine lactate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00663MIG. Most nations, for tariff and trade purposes, schedule bamipine lactate under HS 29333999 and SITC 51574. As of Q4 2014, BAMIPINE LACTATE remains US FDA's Preferred Term for this commodity. Bamipine lactate bears US NLM identifiers UMLS ID C0771814 and NCI Concept Code C97686. SMILES: CC(C(=O)O)O.CN1CCC(CC1)N(CC2CCCCC2)C3CCCCC3.
Same parent
Under 51313200 · 20Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.